{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T18:10:15Z","timestamp":1785435015738,"version":"3.56.0"},"reference-count":0,"publisher":"Ivyspring International Publisher","issue":"13","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Theranostics"],"published-print":{"date-parts":[[2020]]},"DOI":"10.7150\/thno.46691","type":"journal-article","created":{"date-parts":[[2020,5,3]],"date-time":"2020-05-03T10:55:32Z","timestamp":1588503332000},"page":"5932-5942","source":"Crossref","is-referenced-by-count":118,"title":["Optimizing use of theranostic nanoparticles as a life-saving strategy for treating COVID-19 patients"],"prefix":"10.7150","volume":"10","author":[{"given":"Rasha","family":"Itani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mansour","family":"Tobaiqy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Achraf","family":"Al Faraj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"4137","container-title":["Theranostics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thno.org\/v10p5932.htm","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,3]],"date-time":"2020-05-03T10:56:27Z","timestamp":1588503387000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thno.org\/v10p5932.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"references-count":0,"journal-issue":{"issue":"13"},"URL":"https:\/\/doi.org\/10.7150\/thno.46691","relation":{},"ISSN":["1838-7640"],"issn-type":[{"value":"1838-7640","type":"print"}],"subject":[],"published":{"date-parts":[[2020]]}}}